US Stock MarketDetailed Quotes
IBIO iBio Inc
- 2.2100
- +0.0600+2.79%
Close Jul 22 16:00 ET
19.06MMarket Cap-870P/E (TTM)
2.2650High2.1300Low51.98KVolume2.2000Open2.1500Pre Close114.48KTurnover0.79%Turnover RatioLossP/E (Static)8.62MShares15.988052wk High0.77P/B14.64MFloat Cap1.021452wk Low--Dividend TTM6.62MShs Float30300.0000Historical High--Div YieldTTM6.28%Amplitude1.0214Historical Low2.2020Avg Price1Lot Size
iBio Inc Stock Forum
Sign in to post a comment
$iBio Inc(IBIO.US$have news no volume sad
$iBio Inc(IBIO.US$ iBio Receives Notice of Allowance for US Patent Application 17/821,295 Titled "Anti-CD-25 Antibody for the Treatment of Cancer"
Benzinga06/26/2024 11:30
Benzinga06/26/2024 11:30
$iBio Inc(IBIO.US$ Reuters· 1 min ago1min
ibio Inc - Ibio CDMO LLC Entered Into Purchase, Sale Agreement, Dated as of May 17, With Board of Regents of Texas a&M University System, property will be sold to board of regents for 8.5 million
ibio Inc - Ibio CDMO LLC Entered Into Purchase, Sale Agreement, Dated as of May 17, With Board of Regents of Texas a&M University System, property will be sold to board of regents for 8.5 million
$iBio Inc(IBIO.US$
Summary by Moomoo AI
iBio Inc, a preclinical stage biotechnology company, has filed a prospectus related to the resale of up to 10,574,556 shares of common stock by identified selling stockholders. These shares include 2,701,315 outstanding shares held by the selling stockholders, 2,585,963 shares issuable upon the exercise of pre-funded warrants, and 5,287,278 shares issuable upon the exercise of outstanding warrants. The selling stockholders acquired these shares a...
Summary by Moomoo AI
iBio Inc, a preclinical stage biotechnology company, has filed a prospectus related to the resale of up to 10,574,556 shares of common stock by identified selling stockholders. These shares include 2,701,315 outstanding shares held by the selling stockholders, 2,585,963 shares issuable upon the exercise of pre-funded warrants, and 5,287,278 shares issuable upon the exercise of outstanding warrants. The selling stockholders acquired these shares a...
$iBio Inc(IBIO.US$ no buying queue....
$iBio Inc(IBIO.US$
I think resistance is around 3.37 with support at 2.80. I'm hoping for input on what I've come up with. I've only tried to map out a stock a couple of times. My hope is it will go back to 4.20ish by tomorrow. Don't buy based on my prediction, I don't know if I'm looking at this right lol.
I think resistance is around 3.37 with support at 2.80. I'm hoping for input on what I've come up with. I've only tried to map out a stock a couple of times. My hope is it will go back to 4.20ish by tomorrow. Don't buy based on my prediction, I don't know if I'm looking at this right lol.
1
4
$iBio Inc(IBIO.US$ big bid/ask gap.....
1
$iBio Inc(IBIO.US$ bleed....
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Trytosaveabit : Sad isn’t it, how one can get a patent and goes 100%+ and another gets a very similar patent ( meaning in same field/type ) and can’t even get a bit of volume? Hehehe! In its defense though. Sometimes I’ve seen patent news take a day or 3 to move a tickers price? GL to ya